Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
146.80    0.60 (0.41%)
Bid:
144.20
Ask:
147.00
Spread: 2.80 (1.942%)
Market Cap: £250.83m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

AGM Trading Update

23 Oct 2018 07:00

RNS Number : 8214E
McBride PLC
23 October 2018
 

23 October 2018

 

McBride plc

 

AGM Trading Update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, provides the following trading update ahead of its 2018 Annual General Meeting later today.

 

The Group's first quarter continuing revenues at constant currency were 15.4% higher than the prior year. Excluding the benefit of first quarter revenues from Danlind, continuing underlying revenues were 5.5% higher. Underlying Household division sales were 5.3% higher, primarily as a result of higher sales in the East and UK regions (up 20.8% and 11.3% respectively). Our expectations for full year revenues are unchanged.

 

During the first quarter, raw material and packaging costs together with logistics costs, especially in northern Europe, have been slightly higher than anticipated but have been mitigated by improved sales volumes and lower overheads. At this time, there is increased volatility and uncertainty around future raw material and packaging cost levels and whilst the Group will always seek to recover or mitigate any increased input inflation, the timing of these actions typically lag their impact. In the absence of further near term raw material and packaging cost rises, the Board expects full year earnings to be in line with expectations.

The sale of the European Personal Care (PC) Liquids business remains on track, with completion expected in the final quarter of 2018, as previously announced, and the integration of Danlind is progressing well.

 

Rik De Vos, Chief Executive said;

 

"The Group is busy completing the sale of PC Liquids, integrating Danlind and managing revenue growth to expectations. Margins continue to be a key focus especially against the backdrop of potentially further increased input costs. We continue to outperform our sector both financially and operationally in what is a particularly challenging environment and the Group is strongly positioned to exploit further growth and margin opportunities in the coming year and beyond."

 

 

For further information please contact:

 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAPEAAAPPFFF
Date   Source Headline
16th Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20266:11 pmRNSDirector/PDMR Shareholding
12th Jun 20267:00 amRNSTrading and Acquisition Update
11th Jun 20261:44 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSSecond tranche of share buyback programme
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSProposed Acquisition & Trading Conditions Update
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector Appointment
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20266:28 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.